AI-generated summary
In this small randomized single-blind trial, the authors treated facial acne scars in patients with Fitzpatrick skin types IV to VI using a 1,550-nm erbium fractional laser at two energy levels over five monthly sessions. They report significant improvement in scarring and overall appearance, with no significant difference between energy levels and high patient satisfaction. Significant postinflammatory hyperpigmentation and greater pain in darker skin were also reported.
- Participants
- 15
- Who or what was studied
- Patients with facial acne scars, Fitzpatrick skin types IV to VI
- Limits stated in the abstract
- The abstract describes a small sample of 15 patients and does not report a control group or long-term follow-up.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.